Patricia Bravo
Field
School/Institution
| Undergrad | De La Salle University Biochemistry |
|---|---|
| Masters | Université D' Angers Université de Paris University of Patras Nanomedicine |
Featured on February 16, 2020
Bonjour! Meet our featured scientist of the week, Patricia Bravo! Patricia, or Pat is currently a Master’s student taking the Erasmus Mundus Nanomedicine for Drug Delivery Programme (NANOMED).
Like other Erasmus programmes, NANOMED actively promotes student mobility and so since starting, Pat has studied at the University of Patras in Greece, as well as the Université de Paris and Université D’ Angers, both in France.
Before becoming an academic jetsetter, Pat took up her Bachelor’s degree in Biochemistry at De La Salle University, Manila. There, she applied computational biochemistry in studying specific proteins of Anopheles gambiae, a mosquito that carries malaria. Now, Pat is working on cerium oxide nanoparticles that can dissolve clots in ischemic stroke patients.
Fun fact: Pat stands at 5 feet tall, and has always been described as “small.” Coincidentally, she’s now in a field that takes advantage of “smallness” (at the nanometer-level, to be specific) to make a big impact on drug delivery! Let’s all welcome Pat to the Pinoy Scientists community!
Updates
Updated on September 30, 2024
It’s been more than four years since Patricia Bravo contributed to Pinoy Scientists! When she was first on our Instagram, we caught her at the tail end of her Master’s studies at the Erasmus Mundus Nanomedicine for Drug Delivery Programme (NANOMED) where she worked on cerium oxide nanoparticles as a treatment for ischemic stroke patients.
Since then, Patricia has not only finished her Master’s program but has also just recently defended her PhD work at the Swiss Tropical and Public Health Institute, University of Basel in Switzerland. Awarded with summa cum laude, Patricia also has several papers on the way! Her graduate research involved the development of a new proteomics approach that may assist with the identifying of malarial targets and the discovery of a new class of antimalarial compounds.
